JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

JNJ

226.93

+0.75%↑

ABT

93.34

+0.83%↑

MDT

81.35

-2.02%↓

A

114.84

-0.43%↓

VEEV

158.17

-1.76%↓

Search

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

10.8 0.75

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.42

Max

10.86

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+2.9% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-46M

870M

Ouverture précédente

10.05

Clôture précédente

10.8

Sentiment de l'Actualité

By Acuity

50%

50%

157 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 avr. 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 avr. 2026, 23:08 UTC

Résultats
Principaux Mouvements du Marché

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 avr. 2026, 23:58 UTC

Résultats

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 avr. 2026, 23:58 UTC

Résultats

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 avr. 2026, 23:56 UTC

Résultats

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 avr. 2026, 23:56 UTC

Résultats

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 avr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 avr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 avr. 2026, 23:34 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 avr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 avr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 avr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 avr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 avr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 avr. 2026, 22:10 UTC

Résultats

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 avr. 2026, 21:56 UTC

Résultats

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 avr. 2026, 21:55 UTC

Résultats

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 avr. 2026, 21:55 UTC

Résultats

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 avr. 2026, 21:44 UTC

Résultats

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 avr. 2026, 21:43 UTC

Résultats

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 avr. 2026, 21:41 UTC

Résultats

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 avr. 2026, 21:41 UTC

Résultats

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 avr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 avr. 2026, 20:39 UTC

Résultats

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

2.9% hausse

Prévisions sur 12 Mois

Moyen 11 USD  2.9%

Haut 12 USD

Bas 9 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

6 ratings

0

Achat

4

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

157 / 348Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat